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How growing axons are guided to their targets has 
been the subject of much speculation. A popular 
hypothesis i  that there are macromolecules in the ex- 
tracellular matrix (ECM) or on the surfaces of other 
cells that form pathways for axon guidance. Such 
molecular signals could act via a number of different 
mechanisms. One way of directing neurite growth is by 
providing a very adhesive surface for growth cone at- 
tachment (Letourneau 1975). There are, however, 
more elaborate ways in which such molecules could 
function. For instance, the extracellular signals could 
be recognized by surface receptors n the axons, or be 
internalized where they could influence the rate or 
direction of neurite growth. Nerve growth factor 
(NGF), for instance, can act as a chemoattractive agent 
by binding to growing neurites (Gundersen and Barrett 
1980; Claude et al. 1982). A variety of cells, both non- 
neuronal and neuronal, might synthesize guidance 
molecules. Clearly, all target cells are candidates for 
synthesizing these factors, as was demonstrated for 
NGF (Ebendal et al. 1980; Korsching and Thoenen 
1983). If neurons were to secrete guidance or adhesion 
molecules, and deposit hem in an ECM along their ax- 
onal length, then these factors would be ideally local- 
ized for directing regrowth of neurites after axotomy. 
In addition, there is evidence that neuronal surfaces 
contain molecules that are adhesive for other neurites 
or growth cones (Rutishauser et al. 1978; Bentley and 
Keshishian 1982; Tagbert et al. 1982). 
Cell culture has proven to be a useful tool for identi- 
fying molecules that influence the rate or direction of 
neurite growth. Several groups have described factors 
present in conditioned media (CM) that bind to polycat- 
ionic substrata nd stimulate neurite outgrowth from 
peripheral neurons in culture (Collins 1978; Adler et al. 
1981; Coughlin et al. 1981). This biological activity 
appears to be synthesized by many kinds of primary 
cells and cell lines (Adler et al. 1981). The neurite- 
promoting factor contained in bovine corneal endothe- 
lial cell CM has been partially characterized, and the 
activity is associated with a heparan sulfate proteogly- 
can (Lander et al. 1982). In the hope of studying the 
distribution and function of such molecules in vivo, 
several groups have initiated an immunological ap- 
proach. Coughlin and Kessler (1982) have recently 
developed a polyclonal antiserum to a partially purified 
CM factor. This antiserum blocks neurite outgrowth in 
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vitro. Although it is probable that this antiserum con- 
tains antibodies directed against he functional site of 
the active molecule, it is likely that such antisera lso 
contain antibodies directed at contaminants in the 
preparation. 
An alternate approach is to use hybridoma methods 
to develop highly specific antibodies to impure mate- 
rial. Matthew and colleagues (1982, 1983) have de- 
scribed five monoclonal antibodies--pg3, pgl5, pg22, 
pg3 l, and pg42--that precipitate a heparan sulfate pro- 
teoglycan from pheochromocytoma (PC12) cell CM 
and, in doing so, deplete CM of its ability to induce 
rapid neurite outgrowth. However, when these anti- 
bodies are adsorbed to CM-coated dishes, there is no 
inhibition of the outgrowth-promoting activity. There- 
fore, it is unclear if the heparan sulfate proteoglycan is 
directly responsible for promoting neurite growth or if 
it is merely required to adsorb an associated molecule 
(the active factor) to the polycationic culture surface. 
Obviously, if a monoclonal antibody could be devel- 
oped that directly blocked the neurite-promoting activ- 
ity of the CM factor, it would be an appropriate probe 
for (1) studying the biochemical properties of this fac- 
tor, (2) determining if various CM preparations contain 
identical molecules, (3) localizing the activity in situ 
throughout development, and (4) determining the 
mechanism by which this molecule licits neurite out- 
growth. With these goals in mind, we have developed a 
monoclonal antibody--INO (inhibitor of neurite out- 
growth)--which, when adsorbed to CM-coated dishes, 
blocks the neurite-promoting activity. We describe be- 
low the novel method used to produce this antibody and 
our preliminary results on the biochemical characteriza- 
tion and in situ localization of this activity. 
METHODS 
Cell culture and CM preparation. Normal PCI2 
cells and F3 cells (mutant PCI2 cells secreting an al- 
tered form of the heparan sulfate proteoglycan that is 
not able to induce neurite outgrowth [Matthew et al. 
1982]) were maintained in L15-CO2 medium (Hawrot 
and Patterson 1979), supplemented with 10% fetal calf 
serum and 5% horse serum. Each cell line was grown 
in medium containing NGF and serum for 2 weeks and 
then rinsed thoroughly with serum-free medium. Cells 
were grown in serum-free medium for 12 hours and 
rinsed and then fresh medium was added. After 3 days, 
500 ml of CM was collected and adsorbed to 20 ml of 
DEAE-cellulose quilibrated with 150 mM NaCl. The 
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column was washed with 150 mM NaCI, and the neurite 
outgrowth activity and heparan sulfate proteoglycan 
were eluted with 1.5 M NaCI and stored frozen at 
-20~ 
A nonneuronal, fibroblastlike cell line, which was 
established from primary dorsal root ganglia (DRG) 
cultures (Matthew 1981), secretes a highconcentration 
of neurite-promoting activity. Cells w re grown to con- 
fluence in L15-CO2 containing 10% fetal calf serum 
and rinsed in serum-free medium. The cells were 
grown for 2 days in serum-free medium, rinsed, and 
maintained until the m dium started to turn acidic (4-8 
days). The final collection of conditioned medium was 
then fractionated on DEAE-cellulose, as previously 
described. 
lectin, centrifuged, and finally sterilized by passage 
through a 0.2-#m Millipore filter. This T-cell CM was 
diluted with an equal volume of fresh medium (without 
Con A), and the fetal calf serum was adjusted to20% 
of the total volume. Muramyl di-peptide (Adjuvant pep- 
tide, Sigma) was added to this medium at a concentra- 
tion of 25/zg/ml. The spleen from the mouse that had 
been primed and treated with cyclophosphamide was 
dissociated and plated into 10 ml of the diluted T-cell 
medium, which contained 10 ng of antigen from PC12 
cell CM. The cells were plated at 10 7 cells/ml in a 
25-cm 2 tissue culture flask (Corning #25100) stood up- 
right and incubated for 3.5 days. In our more recent 
work, we double the culture volume with fresh medium 
(without antigen) each day. 
Assay for inhibition of neurite outgrowth. Glass 
coverslips were cleaned with concentrated sulfuric 
acid, rinsed with distilled water and then with 0.1 M 
NaOH, air-dried, and reacted with aminopropyltri- 
ethoxysilane (Sigma) for 3 minutes. After extensive 
washing with distilled water and then sterile phosphate 
buffer, coverslips were incubated with CM overnight at 
4~ The surface was rinsed thoroughly with fresh cul- 
ture medium and incubated with hybridoma culture 
supernatants for 1 hour at room temperature followed 
by 5-12 hours at 4~ The coverslips were rinsed, and 
primary sympathetic neurons were plated in L15-CO2 
medium in the absence of serum. Process outgrowth 
was assayed between 4 and 12 hours later. In some ex- 
periments, the coverslips were UV-irradiated in a lami- 
nar flow hood to ensure sterile conditions prior to plat- 
ing neurons. 
Immunization--Cyclophosphamide treatment. A 
6-week-old, female BALB/c mouse was immunized in- 
traperitoneally with 10 #g of DEAE-fractionated F3 
(mutant PC12 cell line) CM in Freund's complete ad- 
juvant. Two days later, this mouse was injected intra- 
peritoneally with the immunosuppressant drug cyclo- 
phosphamide (40 mg/kg, Cytoxan, Mead Johnson) in 
saline. Three weeks after the initial immunization, the 
spleen was removed, dissociated, and sensitized in
vitro with 10 ng of DEAE-fractionated normal PC12 
CM. Fusion to NS1 myeloma cells was performed 3.5 
days later. 
In vitro immunization. Stimulated T-cell-condi- 
tioned medium was prepared by incubating washed 
spleen cells in standard L15-CO2 medium (our more 
recent work uses FI2 medium) supplemented with 
vitamins (Hawrot and Patterson 1979), 5• 10 -3 M 
2-mercaptoethanol, 100 U/ml penicillin, 100 /~g/ml 
streptomycin, 2 mM glutamine, 6 mg/ml glucose, 10% 
prescreened fetal calf serum (lot #100361, Sterile 
Systems Inc., Logan, Utah), and 4/~g/ml Con-A lectin 
(Sigma #C2010, grade IV). Cells were plated at a den- 
sity of 5 • 106 lymphocytes/ml in a 75-cm 2flask and 
grown for 48 hours in a 5% CO2 atmosphere. Cells 
were centrifuged, and the CM was adsorbed to approxi- 
mately 1 ml of swollen Sephadex G-25 to remove the 
3ss labeling of cells. The DRG nonneuronal cell 
line was grown to confluence in 75-cm 2 flasks in 
L15-CO2 medium containing 10% fetal calf serum and 
then maintained for 2 weeks in serum-free L15-CO2. 
Cultures were briefly rinsed in sulfate-free L15-CO2, 
and each flash was incubated in 10 mlof L15-CO2 con- 
taining 1 mCi of carrier-free [35S]sulfate (ICN, Irvine, 
Calif.). After 7 days, CM was recovered and stored on 
ice; experiments were completed within 6 days. Ap- 
proximately 1% of the 35S counts were excluded from 
Sephadex G-25. 
Sepharose 4B gel chromatography. 35S-labeled 
CM (5 ml) was incubated in solution with 0.5 ml of 
DEAE (equilibrated with 0.15 M NaCI) for 30 minutes 
at room temperature. The DEAE was packed into a 
column and washed extensively with Hank's buffer 
(GIBCO) followed by 5 ml of Ca++-Mg++-free 
Hank's buffer. The INO antigen was eluted with con- 
centrated Ca+ +-Mg+ +-free Hank's buffer (0.5 M 
NaCI). Fractions were collected, an aliquot of each was 
counted for 3sS, and appropriate samples were pooled. 
Solid guanidine HCI was added to bring an aliquot to a 
concentration of 6 M. This sample was stored overnight 
on ice and chromatographed on a 1-cm x 26-cm column 
of Sepharose 4B equilibrated with Ca + +-Mg + +-free 
Hank's buffer. Single drops (50/d each) were collected 
into individual wells of flexible microtiter dishes. Se- 
quential samples were assayed with either a solid-phase 
radioimmunoassay (Klinman 1972; Matthew 1981) for 
binding of INO, pg42, or a control monoclonal anti- 
body that does not bind this material, or counted for 
3~S in a scintillation counter. Each value cited is the 
average of two samples. The void volume and the total 
volume for this column was determined using Blue 
Dextran and [35S]sulfate. 
Immunocytochemical localization. Unfixed supe- 
rior cervical ganglia were frozen on dry ice, and 10-#m 
sections were cut on a cryostat. Sections were dried on 
glass slides at room temperature and then frozen and 
thawed to facilitate penetration. Sections were incu- 
bated in INO hybridoma culture medium for 30 minutes 
at 4~ and then washed twice with phosphate-buffered 
saline (PBS). Rhodamine-coupled F(abh fragments of 
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goat anti-mouse immunoglobulin (Cappel, Inc.) were 
preincubated for 30 minutes at 4~ in a 1:1 dilution 
with adult rat serum. This olution was diluted 1:100 
with L15-CO2 medium containing 1% FCS and incu- 
bated on the sections for 30 minutes at 4~ After two 
washes with PBS, the slides were mounted in PBS- 
glycerol (1:1) and viewed with a Zeiss inverted micro- 
scope equipped with Epi-illumination and a rhodamine 
filter set using a 40 x objective. Fluorescent exposures 
were for 30 seconds using Ilford HP5-135 film. Omis- 
sion of the INO antibody or incubation with other 
monoclonai antibodies yielded minimal staining. 
6-Hydroxydopamine tr atment. Adult rats were in- 
jected intraperitoneally with 100 mg/kg 6-hydroxydop- 
amine (in 0.9% NaCl plus 0.5 mg/ml ascorbic acid). 
This injection was repeated 12 hours later and twice 
again 7 days later (Finch et al. 1973). Glyoxylic acid 
analysis of catecholamine fluorescence in sympathetic 
axons in the irides confirmed that 12 days after the ini- 
tial injection, the sympathetic innervation was virtually 
eliminated. 
RESULTS 
Even though the five anti-heparan sulfate proteogly- 
can antibodies capable of precipitating the neurite-pro- 
moting activity from PC12 CM did not directly block 
neurite outgrowth when bound to CM-coated culture 
substratum (Matthew et al. 1982), we were optimistic 
that a blocking antibody could be produced. We found 
that both the neurite-promoting activity and the heparan 
sulfate proteoglycan antigen could be concentrated on 
DEAE-cellulose and eluted with high salt. Therefore, 
we produced monoclonal antibodies from mice immu- 
nized with this heparan sulfate proteoglycan prepara- 
tion and screened supernatants for binding to this 
material. After generating 138 monoclonal antibodies 
that bound the CM factor but did not block function, we 
decided to use a new approach. A mouse was immu- 
nized with an inactive heparan sulfate proteoglycan 
preparation obtained from a mutant PC12 cell line (F3; 
Matthew et al. 1982) to initiate a response to the non- 
functional, immunodominant determinants in the CM. 
Two days later, an immunosuppressant drug was in- 
jected. Our strategy was to kill the lymphocytes 
stimulated by these determinants. Three weeks later, 
the spleen was dissociated and immunized in vitro with 
an active CM preparation from normal PC 12 cells. The 
rationale for using the in vitro immunization procedure 
was based on the idea that there is less immunosuppres- 
sion in culture (discussed by Reading 1982). The cells 
were fused to myeloma cells and plated at a clonal dilu- 
tion. From this fusion, 21 hybridoma clones grew and 5 
showed clear binding to CM in a radioimmunoassay. 
We tested these five antibodies for their ability to 
directly block the neurite-promoting activity of CM 
bound to the substratum. Figure 1 shows an example of 
an assay where the INO antibody is able to block the 
outgrowth activity. Unlike th 143 antibodies generated 
by conventional immunizations, none of which could 
block the stimulated neurite outgrowth, four of the five 
antibodies developed with this new procedure did block 
neurite growth in vitro. One of these hybridoma lines, 
INO, has been cloned, and we are beginning to study 
the properties of the antigen recognized by this anti- 
body. 
Our best source for the neurite-promoting activity is 
a nonneuronal cell line isolated from a primary culture 
of newborn rat DRG cells (Matthew 1981). The five 
original monoclonal antibodies that recognize heparan 
sulfate proteoglycan, and precipitate the neurite-pro- 
moting activity from CM, bind the surface of these 
cells in culture (Matthew 1981). The origin of this cell 
line is uncertain. However, the five anti-heparan sulfate 
proteoglycan antibodies tain pericytes and mesangial 
cells around capillaries in situ (N. Dekker, pers. 
comm.). The cell line isolated from DRG secretes a
large amount of the INO antigen as well as the n urite- 
promoting activity. Therefore, we decided to study the 
antigen synthesized by these cells. The neurite-promot- 
ing activity appears to be associated with a heparan 
sulfate proteoglycan fraction, as was the case for the 
activity released by bovine corneal endothelial cells 
(Lander et al. 1982). Since cells incorporate [35S]sul- 
fate primarily into proteoglycans (Okayama et al. 1976; 
Hassell et al. 1980), we labeled the DRG accessory cell 
line with radioactive sulfate and found that the INO an- 
tigen coeluted from DEAE-cellulose with a peak of 
35S-labeled material between 0.3 M and 0.5 M NaC1 
(data not shown). We chromatographed this DEAE 
fraction on Sepharose 4B. Both the pg42 (an antibody 
that binds the core protein of a heparan sulfate proteo- 
glycan [Matthew 1981] and can precipitate he neu- 
rite-promoting activity but not block it directly) and 
INO immunoreactivity coeluted with the majority of 
35S-labeled material that had an apparent molecular 
weight of approximately 10 x 10 6 (data not shown). 
Therefore, it seems likely that the INO determinant is 
either part of the same heparan sulfate proteoglycan 
molecule recognized by the original monoclonal anti- 
bodies (Matthew 1981) or associated with this heparan 
sulfate proteoglycan complex. To assess the latter pos- 
sibility, the sulfate-labeled DEAE fraction was ex- 
tracted in 6 M guanidine to dissociate the proteoglycan 
complex and then chromatographed on Sepharose 4B 
(Fig. 2). The elution profile of 3sS label reflected a 
very heterogeneous size distribution. The binding pat- 
tern of the pg42 antibody shows that the heparan sulfate 
proteoglycan is codistributed with the sulfate label. The 
heterogeneous size distribution could be caused by in- 
complete dissociation of the complex or by reaggrega- 
tion of the proteoglycan during chromatography in 
physiological buffer. 
We see that the INO determinant elutes from this col- 
umn with adifferent profile from the proteoglycan. The 
INO antibody binds only to material eluting with a 
molecular weight of approximately 10 x 10 6. If the 
INO antibody does bind to a heparan sulfate proteogly- 
can, then it recognizes either a unique conformation or 
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Figure 1. Substrata were prepared as described in Methods using CM from the dorsal root ganglia-derived cell line. I  A, 
neurons were plated on CM-treated coverslips that were not incubated with hybridoma fluid. In B, the CM was omitted. C shows 
neurons plated onCM-coated coverslips that were incubated with one of the nonfunction-blocking antibodies which recognizes 
the heparan sulfate proteoglycan (pg22), and in D the substrate was incubated with INO antibody. Neurons were photographed 
10 hr after plating. 
determinant on a subpopulation of heparan sulfate pro- 
teoglycan molecules. Alternatively, the INO determi- 
nant may be on a molecule tightly associated with the 
heparan sulfate proteoglycan, or possibly the determi- 
nant is defined by a conformation resulting from the 
interaction of an associated molecule and the heparan 
sulfate proteoglycan. 
Since the INO antibody recognizes a determinant that 
plays a role in the stimulation of neurite outgrowth in 
vitro, it is of interest o determine the localization of 
this molecule in vivo. Using indirect immunofluores- 
cence techniques, we have begun to examine the distri- 
bution of INO antibody binding. The most striking 
binding seen so far is associated with neural elements, 
particularly during development. For instance, fluores- 
cent staining is seen in the neonatal rat superior cervical 
ganglion (SCG) (Fig. 3A). The extreme sensitivity of 
the antigen to fixation has thus far prevented a detailed 
analysis of the distribution of antigen with the neonatal 
ganglion. In the clearest cases, however, staining ap- 
pears to be associated with neuronal cell bodies. That 
this INO binding is associated with neurite outgrowth is 
supported by the observation of bright staining in 
newborn and 14-day SCG (Fig. 3A,B). However, stain- 
ing is greatly diminished by 21 days of development 
(Fig. 3C) and is rarely seen in the adult ganglion (Fig. 
3D). Thus, the detection of immunoreactivity is cor- 
related with the time of axonal growth. 
To examine this correlation further, the axons of 
adult noradrenergic sympathetic neurons were heavily 
damaged by intraperitoneal injections of 6-hydroxydop- 
amine, a toxic catecholamine congener. In the adult, 
neuronal cell bodies survive this treatment and regrow 
axons back into targets (Finch et al. 1973). At the time 
this regrowth is occurring (12 days after the first injec- 
tion), the INO staining is apparent in the adult SCG 
(see Fig. 3E-I). Although a detailed time course has 
not yet been established, the staining appears to be 
much heavier at 12 days postinjection than at either 
9 days or 2 months after injection. It is interesting that 
in sections with particularly good tissue preservation, 
the antibody appears to bind to the neuronal nucleus 
(Fig. 3E-H). 
DISCUSSION 
Using standard immunization procedures, we devel- 
oped 138 antibodies that recognize the neurite out- 
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Figure 2. The DRG nonneuronal cell line was grown in [35S]sulfate o label proteoglycans. The CM was fractionated on 
DEAE, incubated in 6 M guanidine, and chromatographed on Sepharose 4B in Ca* +-Mg+ *-free Hank's buffer. Sequential 
drops were assayed for binding of INO, pg42, and 35S. (Kav= elution volume- void volume/total volume- void volume.) 
growth-stimulating preparation, but, like the five 
original antibodies to the heparan sulfate proteoglycan 
(Matthew et al. 1982, 1983), none can directly block 
the neurite-promoting activity in culture. We feel the 
immunological procedures we designed to minimize 
immunodominance and suppression were crucial in de- 
veloping the function-blocking antibody. Using this 
procedure, four out of five antibodies against he CM 
were capable of blocking function. Our strategy of eli- 
citing an immune response to uninteresting deter- 
minants, followed by an immunosuppressant drug to 
destroy the lymphocytes responsible for this reaction, 
should be of general usefulness. It seems likely that we 
did not need to use a mutant heparan sulfate proteogly- 
can in order to initiate a response to uninteresting deter- 
minants-our standard immunizations with heparan sul- 
fate proteoglycan did not appear to elicit a response to 
the functional determinant. Using a variety of immuno- 
gens, we currently are testing this procedure for its 
ability to generate monoclonal antibodies to unique 
determinants. 
Having developed a monocional antibody that blocks 
the function of the neurite-promoting factor, we are in a 
position to characterize this molecule. Our initial find- 
ings argue that if the heparan sulfate proteoglycan is not 
directly responsible for the outgrowth activity, it is cer- 
tainly tightly associated with this factor. If the INO 
antibody does bind the heparan sulfate proteoglycan, it 
must recognize an epitope unique to the complexed 
molecule. It is still possible, however, that the INO de- 
terminant is not on the heparan sulfate proteoglycan it- 
self but on an associated molecule that is either very 
tightly coupled to the heparan sulfate proteoglycan or 
adopts a unique conformation in the aggregate. A key 
experiment that will help resolve this question is to de- 
termine whether the INO determinant is sensitive to 
heparinase treatment (Lander et al. 1982). Of course, if 
the antibody recognizes a particular conformation com- 
posed of both the heparan sulfate proteoglycan and an 
associated molecule, then we will not be able to disrupt 
the complex without destroying antigenicity. 
Since this antibody blocks neurite outgrowth, it is the 
most relevant probe for localizing the activity in situ. 
INO binding is found in the developing SCG, as was 
the binding of the anti-proteoglycan tibodies original- 
ly developed by Matthew and Reichardt (Greif and 
Reichardt 1982). Using immunohistochemistry and 
radioimmunoassay with the original anti-proteoglycan 
antibodies, Greif and Reichardt determined that the 
proteoglycan accumulates in the SCG throughout 
development and reaches a maximum level in the adult. 
The INO determinant differs in that it is present in 
neonates but declines during development as axonal 
outgrowth ceases. However, when adult sympathetic 
neurons are axotomized with 6-hydroxydopamine, the 
INO binding reappears in the adult SCG during the 
period of axonal regeneration. In these preliminary 
studies, binding has not been detected in sympathetic 
target issues. 
A very surprising feature of the staining in adult neu- 
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Figure 3. Indirect immunofluorescence wasused to localize the INO antigen in superior cervical ganglia from newborn (A), 
14-day (B), 21-day (C), and adult (D) rats. E and F show binding to sections of superior cervical ganglia from 6-hydroxydopa- 
mine-treated a ult animals and G and H are the corresponding phase photographs. The arrows indicate nuclear staining. Another 
example of staining in the axotomized SCG is shown in L J illustrates a control section of a 6-hydroxydopamine-treated animal 
that was incubated with rhodamine-coupled second antibody only. Bar in A, 20 #m; all photographs are taken at the same 
magnification. 
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rons is the localization within neuronal nuclei. Why 
should a heparan sulfate proteoglycan complex be lo- 
calized in the nucleus? It is possible that some portion 
of the extracellular neurite outgrowth molecule is inter- 
nalized during growth and transported to the nucleus. 
Another possibility is that we are observing cross-re- 
activity of the INO antibody with an entirely different 
molecule. It will therefore be important to characterize 
the antigen in the developing SCG and in axotomized 
adult neurons, as well as in the active CM. If the bind- 
ing we have detected thus far does represent cross-reac- 
tivity, it is quite a coincidence that the cross-reactivity 
molecule only appears during axonal outgrowth both in 
developing and in adult neurons. If the molecule de- 
tected in the nucleus does turn out to be the heparan 
sulfate proteoglycan-associated ctivity, its mechanism 
of action could be related to differential gene action, as 
opposed to direct mediation of neurite adhesion which 
appears to be the case with N-CAM, for instance 
(Rutishauser and Edelman 1978). 
Henke-Fahle and Bonhoeffer (1983) have recently 
developed a monoclonai antibody that inhibits axonal 
outgrowth from chick retinal explants but does not af- 
fect axon growth from the peripheral neurons. Any re- 
lationship between this molecule and the activity that is 
associated with the heparan sulfate proteoglycan factor 
in the periphery will be elucidated only when each as 
been purified and characterized. We feel that an immu- 
nological approach to neurite growth-promoting factors 
will be crucial in understanding the role of these 
molecules in development. 
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